BRIEF-Nicox and Bausch & Lomb announce FDA acceptance of new drug application for Vesneo

Tue Sep 22, 2015 1:38am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Sept 22 (Reuters) - Nicox SA :

* Bausch & Lomb and Nicox announce FDA acceptance of new drug application for novel glaucoma candidate Vesneo (latanoprostene bunod)

* FDA has set an action date of July 21, 2016 to complete its review, as per the Prescription Drug User Fee Act (PDUFA)

Source text for Eikon: Further company coverage: (Gdynia Newsroom)